Wednesday, 6 July, 2022
HomeOpinionCovid-19 threat to healthcare workers and the desperate scramble for ways to...

Covid-19 threat to healthcare workers and the desperate scramble for ways to protect them

In episode 427 of #CutTheClutter, Shekhar Gupta delves into the risky lives of healthcare workers, and explains the novel use of hydroxychloroquine and BCG vaccine.

Text Size:

New Delhi: Healthcare workers are the most exposed to Covid-19 and are constantly being exposed to large concentrations of the virus. They work overtime and in high levels of stress, which decreases their immunity. They are crucial elements in the battle against the novel coronavirus and everything must be done to protect them.

State of healthcare workers   

When the virus began in China, in the first six weeks only 13 health workers were infected by Covid-19. By 14 February, approximately two months later, 1,716 healthcare workers were infected — more than those infected by SARS in 2003. Six days later, the number increased to 2,055 and then by 3 March, 3,200 medical personnel had been infected. In Italy, the scenario has been much worse, 8.5 per cent of all people infected have been healthcare personnel. Further, twenty per cent of Italy’s entire medical personnel has been infected by Covid-19.

Many healthcare workers have also died of the coronavirus. The first fatality was Li Wenliang, a young ophthalmologist — not a profession normally considered high-risk. His colleague Mei Zhongming, who died the following month, was also an ophthalmologist. The third was a thyroid and breast surgeon. The fourth, a neurosurgeon and hospital director and in Britain, two ear, nose, and throat specialists are in critical condition. These doctors aren’t supposed to be dealing with Covid-19, but due to excess pressure, their help is needed. 

Large economies, like the US, have been struggling to protect their healthcare workers. India will find it even more difficult if the virus starts spreading rapidly. And to tackle such a scenario, Prime Minister Narendra Modi has announced Rs 15,000 crores for health facilities. 

Also read: India’s perfectly-timed lockdown & wartime efforts to find Covid-19 cure

BCG & hydroxychloroquine

In India, the Indian Council of Medical Research (ICMR) has approved the use of hydroxychloroquine as a prophylactic for healthcare workers. There are no randomised clinical trials to prove that this drug will reduce the risk of getting infected by Covid-19, but there has been some anecdotal evidence. This drug has also been used for a very long time, so we know there aren’t any serious side-effects. 

Additionally, BCG, Bacillus Calmette–Guérin, a vaccine for tuberculosis, may reduce the risk of getting infected by Covid-19. Two studies show that it reduces the risk of respiratory infections among people, between 60 and 75 years of age, by 70-80 per cent. It is possible that this vaccine may be helpful in reducing the risk of contracting coronavirus.

Watch the full episode of CTC here:

Also read: Who should live, who should die – the tough choice doctors in Spain are making


Subscribe to our channels on YouTube & Telegram

Support Our Journalism

India needs fair, non-hyphenated and questioning journalism, packed with on-ground reporting. ThePrint – with exceptional reporters, columnists and editors – is doing just that.

Sustaining this needs support from wonderful readers like you.

Whether you live in India or overseas, you can take a paid subscription by clicking here.

Support Our Journalism

Most Popular